|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,940,000 |
Market
Cap: |
401.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.37 - $8.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
227,052 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,078,498 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
81,977 |
Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
Total People Sold |
0 |
0 |
0 |
6 |
Total Sell Transactions |
0 |
0 |
0 |
14 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cassella James V |
Chief Development Officer |
|
2023-02-15 |
4 |
AS |
$8.34 |
$31,375 |
D/D |
(3,762) |
173,061 |
|
0% |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2023-02-15 |
4 |
AS |
$8.34 |
$31,375 |
D/D |
(3,762) |
88,049 |
|
0% |
|
Stuart Nancy |
Chief Operating Officer |
|
2023-02-15 |
4 |
AS |
$8.33 |
$50,380 |
D/D |
(6,048) |
262,596 |
|
0% |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2023-01-30 |
4 |
AS |
$8.35 |
$70,917 |
D/D |
(8,493) |
91,811 |
|
0% |
|
Stuart Nancy |
Chief Operating Officer |
|
2023-01-30 |
4 |
AS |
$8.35 |
$110,220 |
D/D |
(13,200) |
268,644 |
|
0% |
|
Cassella James V |
Chief Development Officer |
|
2023-01-30 |
4 |
AS |
$8.35 |
$84,385 |
D/D |
(10,106) |
176,823 |
|
0% |
|
Becker Marc A. |
Chief Financial Officer |
|
2023-01-30 |
4 |
AS |
$8.35 |
$70,917 |
D/D |
(8,493) |
127,625 |
|
0% |
|
Tung Roger D |
Chief Executive Officer |
|
2023-01-06 |
4 |
AS |
$7.24 |
$66,898 |
D/D |
(9,240) |
971,018 |
|
12% |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
100,304 |
|
12% |
|
Becker Marc A. |
Chief Financial Officer |
|
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
136,118 |
|
12% |
|
Cassella James V |
Chief Development Officer |
|
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
186,929 |
|
12% |
|
Stuart Nancy |
Chief Operating Officer |
|
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
281,844 |
|
12% |
|
Hutt Peter Barton |
Director |
|
2022-10-14 |
4 |
S |
$6.09 |
$21,553 |
D/D |
(3,539) |
29,488 |
|
-38% |
|
Hutt Peter Barton |
Director |
|
2022-10-14 |
4 |
OE |
$2.88 |
$10,192 |
D/D |
3,539 |
33,027 |
|
- |
|
Auchincloss Thomas G |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
34,025 |
|
- |
|
Hoiland Jesper |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
21,525 |
|
- |
|
Aldrich Richard |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
358,500 |
|
- |
|
Hutt Peter Barton |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
29,488 |
|
- |
|
Van Heek Christi |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
42,051 |
|
- |
|
Jaeger Wilfred E |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
21,525 |
|
- |
|
Aldrich Richard |
Director |
|
2022-06-06 |
4 |
B |
$4.75 |
$999,999 |
I/I |
210,526 |
210,526 |
2.1 |
31% |
|
Auchincloss Thomas G |
Director |
|
2022-06-06 |
4 |
B |
$4.75 |
$28,500 |
D/D |
6,000 |
17,625 |
2.39 |
31% |
|
Van Heek Christi |
Director |
|
2022-06-06 |
4 |
B |
$4.75 |
$49,999 |
D/D |
10,526 |
25,651 |
2.39 |
31% |
|
Tung Roger D |
Chief Executive Officer |
|
2022-02-15 |
4 |
AS |
$3.09 |
$41,653 |
D/D |
(13,480) |
980,258 |
|
47% |
|
Stuart Nancy |
Chief Operating Officer |
|
2022-02-14 |
4 |
AS |
$3.08 |
$18,631 |
D/D |
(6,049) |
284,737 |
|
39% |
|
279 Records found
|
|
Page 2 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|